Storia in 2 fonti

Medpace Soars After Q2 Beat, Strong Backlog Fuels 2026 Outlook - Medpace Holdings (NASDAQ:MEDP)

Medpace says second-quarter earnings and revenue beat estimates, backed by stronger bookings, backlog growth and higher 2026 guidance.

Raccontata da

investors.com

benzinga.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo12 g fa

Medpace Soars After Q2 Beat, Strong Backlog Fuels 2026 Outlook - Medpace Holdings (NASDAQ:MEDP)

Medpace beat Q2 estimates with 17.2% revenue growth and raised FY2026 guidance; backlog at $3.01B with 1.13x book-to-bill. Strong CRO performance signals robust biotech R&D investment, key indicator for tech stack spending in drug discovery.

originale

investors.com13 g fa

Medpace Notches A Surprise Beat, Sending Shares Skyward

Medpace stock surged by double digits Thursday, helped by a bookings beat.

Leggi questa versione → originale

Timeline cronologica

mercoledì 22 luglio 2026·investors.com
Medpace Notches A Surprise Beat, Sending Shares Skyward
Medpace stock surged by double digits Thursday, helped by a bookings beat.
giovedì 23 luglio 2026·benzinga.com
Medpace Soars After Q2 Beat, Strong Backlog Fuels 2026 Outlook - Medpace Holdings (NASDAQ:MEDP)
Medpace says second-quarter earnings and revenue beat estimates, backed by stronger bookings, backlog growth and higher 2026 guidance.